Outcomes of Randomized Phase 2 Study in BRAF-Mutated CRC Patients

Howard S. Hochster, MD of Yale Cancer Center discusses the outcomes of the randomized phase 2 study in BRAF-mutated patients with colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (ASCO... Author: obr Added: 01/24/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts